Twist Bioscience

Synthetic DNA for Health & Sustainability #WeMakeDNA #TwistBlog #WritingTheFuture #TwistBiopharma #ScienceDoesntStop #DiversityIsInOurDNA

[Twist Bioscience @TwistBioscience]

You told us FFPE is your toughest sample type. We’re not surprised

57% of respondents named FFPE-degraded tumor tissue their biggest NGS library prep challenge

TrueAmp Library Prep Kit was built to help deliver consistent coverage & reduce target dropout https://t.co/YF2PC5tca6

[Twist Bioscience @TwistBioscience]

This Blood Cancer Awareness Month, see how Twist supports researchers across every stage, helping turn genomic complexity into answers that move research forward: https://t.co/NIrgvPvehQ

@TwistBioscience

[Twist Bioscience @TwistBioscience]

Whole-exome sequencing in individuals with obsessive–compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes

Thank you to the authors for choosing Twist Comprehensive Exome Panel to support this research!
https://t.co/RzrDBSJaaY

[Twist Bioscience @TwistBioscience]

AI-designed sequences can look promising computationally but fail in the lab.

Our guide explores how DNA synthesis & testing close the AI design-build-test-learn loop, & improve the next round of training data: https://t.co/D8dBCbvSvt

@TwistBioscience

[Twist Bioscience @TwistBioscience]

Three vendor shows & complex gene launches down!

Olivia R. & Heley O. hit back-to-back vendor shows at NYU, Mount Sinai, and the Tri-I last week.

It was great to see how many people were genuinely excited about our new complex gene synthesis pipeline.

[Twist Bioscience @TwistBioscience]

'Discovery of the century’: Experts have found secret DNA that could unlock a cancer vaccine
https://t.co/jqa5DySRAo

[Twist Bioscience @TwistBioscience]

AI is rewriting the rules of protein design 🧬

@TwistBioscience & IKP Knowledge Park brought together leaders from AWS, immunitoAI, & PopVax, for a seminar on scaling high-throughput data for biotherapeutic discovery, from de novo antibody generation to gene synthesis at scale.

[IBBIS @IBBIS_bio]

New paper update: providers screen DNA orders against lists of known pathogens and toxins, and AI protein design can rewrite a sequence past those lists.

This IBBIS co-authored paper ran redesigned sequences, cut into fragments, through four screening tools.

[Twist Bioscience @TwistBioscience]

Need lots of genes? 👀 Researchers training or validating AI, we’re looking at you!

Twist Gene Pools enable accurate, uniform, chimera-free gene libraries up to 1.8 kb—making protein engineering more scalable.

Read the white paper: https://t.co/x5QrdhrzV7

[Twist Bioscience @TwistBioscience]

We have physically produced and tested proteins that Claude designed from scratch — and the results, published by Anthropic, give AI-assisted drug discovery its first verifiable performance benchmark…

Claude Runs Autonomous Protein Design Campaign https://t.co/lOj6tUCyAA

[Twist Bioscience @TwistBioscience]

This Blood Cancer Awareness Month, see how Twist supports researchers across every stage, helping turn genomic complexity into answers that move research forward: https://t.co/NIrgvPvehQ

@TwistBioscience

[Twist Bioscience @TwistBioscience]

When AI meets the wet lab, what does that mean for the future?
Brendan Smith of TD Cowen + Twist President & COO Patrick Finn (@genesynthesizer) discuss AI, drug discovery, big tech, wet-lab validation and the future of biological data: https://t.co/GBZZACa4nr
@TwistBioscience

[Twist Bioscience @TwistBioscience]

Whole-exome sequencing in individuals with obsessive–compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes

Thank you to the authors for choosing Twist Comprehensive Exome Panel to support this research!

https://t.co/RzrDBSJaaY

[Twist Bioscience @TwistBioscience]

Three vendor shows & complex gene launches down!

Olivia R. & Heley O. hit back-to-back vendor shows at NYU, Mount Sinai, and the Tri-I last week.

It was great to see how many people were genuinely excited about our new complex gene synthesis pipeline.

[Twist Bioscience @TwistBioscience]

Our latest newsletter has insights on our work with Anthropic, @EmilyLeproust's recent recognition, difficult-to-make sequences, engineered enzymes, CAR-T, population genomics, and more.

https://t.co/EWTpH77c5a

[Twist Bioscience @TwistBioscience]

Ancient DNA work revealing a mystery…

An analysis of bones from ancient people who once lived in Colombia has discovered DNA that does not directly connect them to any other ancient or modern population in South America. https://t.co/SSg6osg0Mq

[Twist Bioscience @TwistBioscience]

Need lots of genes? 👀 Researchers training or validating AI, we’re looking at you!

Twist Gene Pools enable accurate, uniform, chimera-free gene libraries up to 1.8 kb—making protein engineering more scalable.

Read the white paper: https://t.co/x5QrdhrzV7

[Twist Bioscience @TwistBioscience]

Bottom-up reconstruction of synthetic pyrenoids provides insights into the mechanisms and evolution of carbon concentration by EPYC1 proteins

Thank to the @erblabs for choosing Twist DNA to support this research

https://t.co/AhzBuvi2G7

[Twist Bioscience @TwistBioscience]

Engineered bacteria offer a new way to accelerate rock weathering for carbon removal https://t.co/UuxwTwRrYM

[Twist Bioscience @TwistBioscience]

When AI meets the wet lab, what does that mean for the future?
Brendan Smith of TD Cowen + Twist President & COO Patrick Finn (@genesynthesizer) discuss AI, drug discovery, big tech, wet-lab validation and the future of biological data: https://t.co/GBZZACa4nr
@TwistBioscience